HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

nafamostat

inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Also Known As:
6'-amidino-2-naphthyl 4-guanidinobenzoate; 6'-amidino-2-naphthyl 4-guanidinobenzoate, dimethanesulfonate; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dihydrochloride; Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dimethanesulfonate; CKD-314; CKD314; FUT 175; FUT-175; Ronastat; nafamostat dihydrochloride; nafamostat mesilate; nafamostat mesylate; nafamstat mesilate
Networked: 409 relevant articles (67 outcomes, 74 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Uwagawa, Tadashi: 22 articles (01/2022 - 05/2007)
2. Yanaga, Katsuhiko: 21 articles (01/2022 - 08/2009)
3. Shiba, Hiroaki: 15 articles (01/2022 - 10/2010)
4. Ohashi, Toya: 15 articles (01/2021 - 10/2010)
5. Furukawa, Kenei: 12 articles (01/2022 - 10/2010)
6. Fujiwara, Yuki: 12 articles (01/2018 - 10/2010)
7. Haruki, Koichiro: 10 articles (01/2018 - 07/2011)
8. Misawa, Takeyuki: 10 articles (02/2015 - 08/2009)
9. Shirai, Yoshihiro: 8 articles (01/2022 - 01/2016)
10. Iwase, Ryota: 8 articles (01/2018 - 11/2012)

Related Diseases

1. Pancreatitis
2. COVID-19
3. Pancreatic Neoplasms (Pancreatic Cancer)
4. Hemorrhage
5. Disseminated Intravascular Coagulation

Related Drugs and Biologics

1. Protease Inhibitors (Protease Inhibitor)
2. Serine Proteinase Inhibitors (Serine Protease Inhibitors)
3. Anticoagulants
4. Complement System Proteins (Complement)
5. Gemcitabine
6. Heparin (Liquaemin)
7. Gabexate (Foy)
8. Dacarbazine (DIC)
9. Serine Proteases (Serine Protease)
10. Oxygen (Dioxygen)

Related Therapies and Procedures

1. Intra-Arterial Infusions
2. Therapeutics
3. Cardiopulmonary Bypass (Heart-Lung Bypass)
4. Extracorporeal Circulation
5. Intravenous Infusions